300
Patients receiving an anticholinergic agent and bromocriptine mesylate (Parlodel) for
Parkinson’s disease should be assessed for
What is baseline neurological data once per shift, constipation and/or urinary retention, and gastrointestinal symptoms (e.g., nausea, abdominal discomfort)?